DCM
NEOS

Diag Capital Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Diag Capital Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$278K Buy
+168,642
New +$473K 0.32% 39

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diag Capital Management's NEOS Position: Q4 2018 in Review

Diag Capital Management opened a new position in Neos Therapeutics, Inc (NEOS) in Q4 2018: 168,642 shares worth $278K. The stake represents 0.32% of the portfolio and ranks #39 among its holdings.

63 funds tracked by Wall St. Rank hold NEOS as of Q4 2018.

  • Diag Capital Management held 168,642 shares of Neos Therapeutics, Inc worth $278K as of Q4 2018.
  • Neos Therapeutics, Inc was a new Diag Capital Management position in Q4 2018.
  • Neos Therapeutics, Inc made up 0.32% of Diag Capital Management's portfolio in Q4 2018, its #39 holding.
  • 63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.